Rheumatological complications of Covid 19

Zacharias, Hannah; Dubey, Shirish; Koduri, Gouri; D’Cruz, David

doi:10.1016/j.autrev.2021.102883

Cited by 93 publications

(91 citation statements)

References 160 publications

(167 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Complications following COVID-19 infection are the focus of numerous clinical trials [9][10][11][12][13]. Pathological changes following COVID-19 infection have also been described in the locomotor system [1].…”

Section: Discussionmentioning

confidence: 99%

Avascular Necrosis Bone Complication after Active COVID-19 Infection: Preliminary Results

et al. 2021

View full text Add to dashboard Cite

Background and objectives: The course of SARS-CoV-2 (COVID-19) is still under analysis. The majority of complications arising from the infection are related to the respiratory system. The adverse effect of the viral infection on bone and joint tissue has also been observed. Materials and Methods: We present a group of 10 patients with degeneration of large joints and adjacent epiphyses of long bones and the spine, with a background of bone infarctions and avascular necrosis (AVN) immediately after infection with the COVID-19 virus. In MR imaging, changes in the characteristics of AVN were documented. Results: Observation of this group showed a clear correlation among the history of COVID-19 disease in the patients, moderately severe symptoms, high levels of IgG antibodies, and the time of occurrence of joint changes. No other clinically significant complications were observed following COVID-19 infection in the study group. No other risk factors for AVN or autoimmune or degenerative diseases were found in the study group. The group of patients responded well to empirical treatment with steroids, which normalized acute inflammatory symptoms and pain in the joints. Conclusions: During coronavirus (COVID-19) infection, there are complications in the locomotor system, such as microembolism and the formation of AVN; hence, more research is needed.

show abstract

Section: Discussionmentioning

confidence: 99%

Avascular Necrosis Bone Complication after Active COVID-19 Infection: Preliminary Results

et al. 2021

View full text Add to dashboard Cite

show abstract

“…4) Some patients have developed different forms of vasculitis (small vessel, middle vessel, large vessel, IgA, cutaneous, CNS vasculitis etc.) in which the inflammation is not limited to the endothelium, but manifests as a peri-and pan-arteritis with immune complex depositions[Reviewed in (186,198)]. A more severe form of vasculitis is the Kawasaki-like disease (KD-like) or Multisystem Inflammatory Syndrome in children with COVID-19.…”

Section: Complementmentioning

confidence: 99%

“…6) Cases of inflammatory arthritis or spondyloarthropathy, usually 1-3 weeks after the infection have also been recorded (198).…”

Section: Complementmentioning

confidence: 99%

See 1 more Smart Citation

COVID-19 Immunobiology: Lessons Learned, New Questions Arise

et al. 2021

View full text Add to dashboard Cite

There is strong evidence that COVID-19 pathophysiology is mainly driven by a spatiotemporal immune deregulation. Both its phenotypic heterogeneity, spanning from asymptomatic to severe disease/death, and its associated mortality, are dictated by and linked to maladaptive innate and adaptive immune responses against SARS-CoV-2, the etiologic factor of the disease. Deregulated interferon and cytokine responses, with the contribution of immune and cellular stress-response mediators (like cellular senescence or uncontrolled inflammatory cell death), result in innate and adaptive immune system malfunction, endothelial activation and inflammation (endothelitis), as well as immunothrombosis (with enhanced platelet activation, NET production/release and complement hyper-activation). All these factors play key roles in the development of severe COVID-19. Interestingly, another consequence of this immune deregulation, is the production of autoantibodies and the subsequent development of autoimmune phenomena observed in some COVID-19 patients with severe disease. These new aspects of the disease that are now emerging (like autoimmunity and cellular senescence), could offer us new opportunities in the field of disease prevention and treatment. Simultaneously, lessons already learned from the immunobiology of COVID-19 could offer new insights, not only for this disease, but also for a variety of chronic inflammatory responses observed in autoimmune and (auto)inflammatory diseases.

show abstract

“…Additionally, severe rheumatological illness has also been reported post infection. Vasculitis and renal dysfunction are other related complications which are reported to be common complications [3]. Acute kidney infection and associated renal diseases are other reported complications post viral infections [4].…”

Section: Introductionmentioning

confidence: 99%

Jeopardy of COVID-19: Rechecking the Perks of Phytotherapeutic Interventions

et al. 2021

View full text Add to dashboard Cite

The novel coronavirus disease (COVID-19), the reason for worldwide pandemic, has already masked around 220 countries globally. This disease is induced by Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2). Arising environmental stress, increase in the oxidative stress level, weak immunity and lack of nutrition deteriorates the clinical status of the infected patients. Though several researches are at its peak for understanding and bringing forward effective therapeutics, yet there is no promising solution treating this disease directly. Medicinal plants and their active metabolites have always been promising in treating many clinical complications since time immemorial. Mother nature provides vivid chemical structures, which act multi-dimensionally all alone or synergistically in mitigating several diseases. Their unique antioxidant and anti-inflammatory activity with least side effects have made them more effective candidate for pharmacological studies. These medicinal plants inhibit attachment, encapsulation and replication of COVID-19 viruses by targeting various signaling molecules such as angiotensin converting enzyme-2, transmembrane serine protease 2, spike glycoprotein, main protease etc. This property is re-examined and its potency is now used to improve the existing global health crisis. This review is an attempt to focus various antiviral activities of various noteworthy medicinal plants. Moreover, its implications as prophylactic or preventive in various secondary complications including neurological, cardiovascular, acute kidney disease, liver disease are also pinpointed in the present review. This knowledge will help emphasis on the therapeutic developments for this novel coronavirus where it can be used as alone or in combination with the repositioned drugs to combat COVID-19.

show abstract

Rheumatological complications of Covid 19

Cited by 93 publications

References 160 publications

Avascular Necrosis Bone Complication after Active COVID-19 Infection: Preliminary Results

Avascular Necrosis Bone Complication after Active COVID-19 Infection: Preliminary Results

COVID-19 Immunobiology: Lessons Learned, New Questions Arise

Jeopardy of COVID-19: Rechecking the Perks of Phytotherapeutic Interventions

Contact Info

Product

Resources

About